title: Just how useful an endpoint is complete pathological response after neoadjuvant chemoradiation in rectal cancer?
authors.forename: Rob
authors.initials: R
authors.lastname: Glynne-Jones
authors.forename: Nicola
authors.initials: N
authors.lastname: Anyamene
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D023381:Endpoint Determination / Q000379:methods / Q000592:standards*; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging / Q000379:methods / Q000592:standards*; D011879:Radiotherapy Dosage; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil